APPLICATIONS PUBLISHED 15 JANUARY 2003
Published: 1-Jul-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Device for applying active principles for pharmaceutical or cosmetic purposes
3K engineering 1274396*
Drug delivery compsn and device
Massachusetts Institute of Technology 1274397*
Effervescent granules and method for their preparation
Ethypharm 1274398*
Liposomes containing an entrapped compound in supersaturated solution
Alza Corp 1274399*
Physically stabilised dry powder formulations
Dura Pharmaceuticals 1274400*
Stable pharmaceutical compsns containing 7-substituted-3,5-dihydroxyheptanoic acids or 7-substituted-3,5-dihydroxyheptanoic acids
Teva Pharmaceutical Industries 1274401*
Pharmaceutical compsn for the controlled release of paracetamol
SmithKline Beecham 1274402*
Particulate compsn
University College Cardiff Consultants 1274403*
Method and compsn for treating cancer by administration of apoptosis-inducing chemotherapeutic agents
Teva Pharmaceutical Industries 1274404*
Transdermal or transmucosal dosage forms with a nicotine-containing active substance combination for nicotine disintoxication
LTS Lohmann Therapie-Systeme 1274405*
Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets
Chiesi Farmaceutici 1274406*
Use of PPAR-gamma agonists in neutrophil-induced diseases
SmithKline Beecham 1274407*
Use of natural chrysanthone compounds having antiangiogenic activity
Sigma-Tau Industrie Farmaceutiche Riunite 1274408*
Antiprogestins with partial agonist activity
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services 1274409*
Use of locally applied DNA fragments
Trustees of Boston University 1274410*
Phenylethylamines and condensed rings variants as prodrugs of catecholamines and their use
Axon Biochemicals 1274411*
Pharmaceutical formulation
Abbott 1274412*
IL-8 receptor antagonists
SmithKline Beecham 1274413*
Nasal handling of agents for the treatment of gastroparesis
Questor Pharmaceuticals; Shire US 1274414*
IL-8 receptor antagonists
SmithKline Beecham 1274415*
Dermatological use and a dermatological preparation
Ipsat Therapies 1274416*
Treatment of movement disorders with metabotropic glutamate receptor antagonists
Motac Neuroscience 1274417*
Methods of use of penicillamines for the treatment of conditions resulting from DNA damage
Niadyne Corp; University of Kentucky Research Foundation 1274418*
Zinc amino acid chelates having ligands comprised of glycine and a sulphur-containing amino acid
Albion International 1274419*
Microbial inhibitory compsns
Unisearch 1274420*
Use of substances that act as cascade inhibitors of the RAF/MEK/ERK signal cascade, for producing a medicament to treat DNA and RNA viruses
Transmit Gesellschaft fuer Technologietransfer 1274421*
Method for treating cells resistant to antineoplastic agents
Novartis 1274422*
Medicine for treating traumatic brain injury and other neuronal disorders
Virginia Commonwealth University Intellectual Property Foundation 1274423*
Compounds and methods
SmithKline Beecham 1274424*
Rapid-onset formulation of a selective cyclooxygenase-2 inhibitor
Pharmacia 1274425*
Use of thioamide oxazolidinones for the treatment of bone resorption and osteoporosis
Pharmacia & Upjohn 1274426*
Formulation of substituted benzimidazoles
AstraZeneca 1274427*
IL-8 receptor antagonists
SmithKline Beecham 1274428*
Topical formulations for the transdermal delivery of niacin and methods of treating hyperlipidaemia
Niadyne; University of Kentucky Research Foundation; Jacobson, Myron; Kim,Hyuntae; Kim, Moonsun; Qasem, Jaber 1274429*
Compounds for treating fibromyalgia and chronic fatigue syndrome
Pharmacia & Upjohn 1274430*
10,11-difluoromethylenedioxycamptothecin compounds with topoisomerase I inhibition
Research Triangle Institute; Bristol-Myers Squibb 1274431*
Compounds containing itraconazole with improved bioavailability and narrow intra- and inter-individual variation of its absorption
Dong A Pharmaceutical 1274432*
Medicaments for treating respiratory disorders comprising formoterol and fluticasone
Innovata Biomed 1274433*
Medical combinations comprising tiotropium and rofleponide
Glaxo Group 1274434*
Medical combinations comprising formenterol and budesonide
Glaxo Group 1274435*
Medical compsns comprising (R,R)-formoterol and rofleponide
Glaxo Group 1274436*
Respiratory compsns
Glaxo Group 1274441*
Method for modulating tumour growth and metastasis of tumour cells
Sloan-Kettering Institute for Cancer Research 1274442*
Micelles
Eisai 1274443*
Compounds for the treatment of psychiatric or substance abuse disorders
The McLean Hospital Corp 1274444*
Use of steroid alkaloids to reverse multidrug resistance
Yeda Research and Development 1274445*
Polysaccharide esters of N-derivatives of glutamic acid
Eurand Pharmaceuticals 1274446*
Pharmaceutical compsn with a content of calcium or mixture of calcium and vitamin D or mixture of calcium and magnesium in a new formulation
Slovakofarma 1274447*
Cytokine uses; compsns; methods
Schering 1274450*
Sperm factor oscillogenin
University of Massachusetts 1274451*
Method of preventing or treating diabetes
Loma Linda University 1274452*
Recombinant intracellular pathogen vaccines and methods for use
The Regents of the University of California 1274453*
Methods and compsns for eliciting an immune response
Chemocentryx 1274454*
CD40 antagonists for use in treating psoriasis and other inflammatory skin conditions
Tanox 1274455*
Use of retinoid receptor antagonists or arsonists in the treatment of cartilage and bone pathologies
Allergan 1274456*
Methods and compsns for the treatment of allergic conditions using PGD2 receptor antagonists
Merck Frosst Canada 1274457*
Compsns containing a naphthalmide and an antiproliferative agent
Chemgenex Therapeutics 1274458*
Sustained release formulations containing growth hormone
Genentech 1274459*
Aqueous-prodrug compound comprising moiety of paclitaxel or derivatives thereof, method of preparing same and pharmaceutical compsn comprising same
Kolon Industries 1274460*
Rhamm peptide conjugates
Cangene Corp 1274461*
